Eton Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 2.85 M | $37.99 M | 2.59% | 11.01% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 1.83 M | $24.37 M | 223.21% | 7.06% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.12 M | $14.90 M | 11.99% | 4.32% |
| VANGUARD GROUP INC | 02/11/2025 | 1.06 M | $14.17 M | 3.50% | 4.11% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 01/17/2025 | 575,222 | $7.66 M | -7.02% | 2.22% |
| 02/14/2025 | 455,805 | $6.07 M | 100.00% | 1.76% | |
| CANNELL CAPITAL LLC | 02/13/2025 | 381,323 | $5.08 M | 100.00% | 1.47% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 317,625 | $4.23 M | 11.50% | 1.23% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 276,890 | $3.69 M | 6.40% | 1.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 268,646 | $3.58 M | -1.49% | 1.04% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 248,505 | $3.31 M | 134.54% | 0.96% |
| ARISTIDES CAPITAL LLC | 02/13/2025 | 241,587 | $3.22 M | 20.79% | 0.93% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 238,962 | $3.18 M | -5.68% | 0.92% |
| WASATCH ADVISORS LP | 02/13/2025 | 231,328 | $3.08 M | -3.03% | 0.89% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 214,878 | $2.86 M | 230.51% | 0.83% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 02/18/2025 | 200,000 | $2.66 M | -33.33% | 0.77% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 193,100 | $2.57 M | 131.53% | 0.75% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 192,326 | $2.56 M | 61.15% | 0.74% |
| ACUITAS INVESTMENTS, LLC | 01/31/2025 | 185,824 | $2.48 M | -67.96% | 0.72% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 151,400 | $2.02 M | -33.60% | 0.58% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 138,887 | $1.85 M | 100.00% | 0.54% |
| UBS GROUP AG | 02/14/2025 | 135,352 | $1.80 M | 611.74% | 0.52% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 129,879 | $1.73 M | 100.00% | 0.50% |
| THOMPSON SIEGEL & WALMSLEY LLC | 02/10/2025 | 128,039 | $1.71 M | 11.31% | 0.49% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 112,458 | $1.50 M | 100.00% | 0.43% |
| STATE STREET CORP | 02/14/2025 | 105,336 | $1.40 M | 29.40% | 0.41% |
| EAM INVESTORS, LLC | 02/13/2025 | 95,019 | $1.27 M | -25.93% | 0.37% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 94,181 | $1.25 M | 191.20% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 89,700 | $1.19 M | 498.00% | 0.35% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 89,664 | $1.19 M | 421.30% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 74,246 | $988,957 | -0.33% | 0.29% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 69,000 | $919,080 | 100.00% | 0.27% |
| JANE STREET GROUP, LLC | 02/14/2025 | 64,323 | $856,782 | 328.65% | 0.25% |
| ANCHOR CAPITAL ADVISORS LLC | 02/05/2025 | 60,432 | $804,954 | 100.00% | 0.23% |
| BARCLAYS PLC | 02/13/2025 | 54,886 | $731,000 | 100.00% | 0.21% |
| JPMORGAN CHASE & CO | 02/12/2025 | 51,961 | $692,121 | 7,086.86% | 0.20% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 49,700 | $662,004 | 100.00% | 0.19% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 43,239 | $575,943 | 422.90% | 0.17% |
| OMERS ADMINISTRATION CORP | 02/14/2025 | 37,900 | $504,828 | 100.00% | 0.15% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 36,376 | $484,000 | 100.00% | 0.14% |
| MARSHALL WACE, LLP | 02/13/2025 | 36,182 | $481,943 | 75.33% | 0.14% |
| BLAIR WILLIAM & CO/IL | 02/12/2025 | 34,900 | $464,868 | 1.16% | 0.13% |
| BAADER BANK AKTIENGESELLSCHAFT | 01/23/2025 | 28,000 | $372,960 | 100.00% | 0.11% |
| JUMP FINANCIAL, LLC | 02/13/2025 | 24,710 | $329,137 | 100.00% | 0.10% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 02/07/2025 | 24,442 | $325,567 | -10.31% | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 24,242 | $322,903 | 100.00% | 0.09% |
| CITIGROUP INC | 02/12/2025 | 21,977 | $292,734 | -17.05% | 0.08% |
| ENVESTNET ASSET MANAGEMENT INC | 02/13/2025 | 17,740 | $236,297 | 100.00% | 0.07% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/11/2025 | 17,003 | $226,480 | 100.00% | 0.07% |
| CHICAGO TRUST CO NA | 01/13/2025 | 16,700 | $222,444 | 0.00% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Eton Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 75 institutional investors and hedge funds held shares of Eton Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Opaleye Management Inc.: 2.85 M
EcoR1 Capital, LLC: 1.83 M
Nantahala Capital Management, LLC: 1.12 M
VANGUARD GROUP INC: 1.06 M
Westside Investment Management, Inc.: 575,222
CANNELL CAPITAL LLC: 381,323
50.72% of Eton Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 12.93 M shares in the last 24 months. This purchase volume represents approximately $157.18 M in transactions.